Publications on Post-Covid Mucormycosis: A Bibliometric Study of WHO Database.

Sharma, Paras; Dubey, Gargee

doi:10.3329/bjms.v20i5.55415

Cited by 6 publications

(6 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[22] Likewise, Sharma and Dubey included early publications of post-COVID mucormycosis included in the WHO (World Health Organization) database, yet only 51 articles were analyzed. [11] Mallikarjun et al also analyzed post-COVID mucormycosis studies and evaluated 154 documents. [12] Nonetheless, the time interval in these studies was limited; consequently, the number of studies analyzed was modest.…”

Section: Discussionmentioning

confidence: 99%

“…[10] However, despite several bibliometric studies on infectious diseases in the literature, few comprehensive studies have focused on summarizing and presenting research on mucormycosis, as they also have limited content. [11,12] Moreover, they can make comparisons between general journals publishing the results of large trials and specialty journals, which are leaders in publishing novelties. The network visualization figures make it easier for readers to understand articles, citations, co-citations, and other bibliometric analysis findings by visualizing them.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of the effect of the COVID-19 pandemic on mucormycosis studies with bibliometric analysis

et al. 2022

View full text Add to dashboard Cite

Background: Coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM) is a relatively new concept in the literature that emerged during the pandemic. Bibliometric analysis is a type of analysis that uses mathematical and statistical methods to study the formal properties of knowledge areas. This study aimed to reveal the main themes, conceptual structures, and trends of bibliometric studies on mucormycosis in 2 different periods, pre-and during the pandemic. Methods: This study consisted of 2 periods: pre-COVID-19 and COVID-19. Articles were collected from the Web of Science (WOS) Core Collection database. We provided AND and OR connectors for the keyword query and selected studies based on relevant keywords. Collected data were classified based on their publication date and examined using the R programming language (Version 4.0.3) package Bibliometrix and SciMAT Software. Results: A total of 1261 articles were investigated, and performance and information structure analyses were conducted. Based on Bradford’s law, the Journal of Fungi was the top-ranked journal in both periods. Cureus and mycoses were placed 2nd and 3rd in the second period. India is the largest contributor. In performance analysis, conceptual structures such as Rhizopus oryzae, epidemiology, diagnosis, management, treatment, and outcomes were at the forefront of mucormycosis publications during the COVID-19 period. Conclusions: Research trends have shifted to the clinical treatment and management of COVID-19. Therefore, pathogenesis, diagnosis, follow-up, and treatment strategies for CAM should be developed in the future.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Evaluation of the effect of the COVID-19 pandemic on mucormycosis studies with bibliometric analysis

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The Journal of Virology (IF 2018 5 4.434) has published the most significant number of articles on CoV (1,128 articles, 6.51% of the total). Sharma and Dubey (2021) conducted an exceptional study that analyzed post-COVID mucormycosis publications with data from the WHO database. The WHO LHT 42,1 database was searched with two simple keywords, "Mucormycosis" and "Covid" which retrieved 40 articles and 01 clinical trials.…”

Section: Literature Reviewmentioning

confidence: 99%

Cluster analysis and network visualization of research in mucormycosis: a scientometric mapping of the global publications from 2011 to 2020

Borgohain

Nazim

Verma

2022

LHT

View full text Add to dashboard Cite

PurposeMucormycosis has evolved as a post-COVID-19 complication globally, especially in India. The research on fungus has been very primitive, and many scientific publications have been discovered. The current COVID-19 pandemic needs further investigation into this unusual fungal infection. This review study aims to provide a pen-picture to researchers, science policymakers and scientists about different bibliometric indicators related to the research literature on mucormycosis.Design/methodology/approachThe quantitative research was conducted using the established procedure of bibliometric investigation on data collected from Scopus from 2011 to 2020 using a validated search query. The search query consisted of keywords “Mucormycosis” or “Mucormycoses” or “Mucormycose” or “Mucorales Infection” or “Mucorales Infections” or “Black Fungus Infection” or “Black Fungus Infections” or “Zygomycosis” in the “Title-Keyword-Abstract” search option for data extraction. The analysis of data is performed using MS-Excel. Mapping was done with state-of-the-art visualization tools Biblioshiny and VOSviewer, using bibliometric indicators as units of analysis.FindingsThe analysis reveals that the first publication on this topic was reported from 1923 onwards. In total, 9,423 authors contributed 1,896 papers with 11,437 collaborated authors, documents per author are 0.201, authors per document are 4.97 and co-authors per document are 6.03. Total records were published in 779 journals in the English language from 75 countries globally. Mucormycosis literature is mostly open access, with 1,210 publications available via different open access routes. The highest number of articles (204) published in the journal “Mycoses” with 1,333 authors received 4,875 cited references, and the h-index has 24. The growth of publications is exponential, as depicted by the Price Law. The USA has recorded a maximum number of publications at both country and institutional levels compared to the other nations. There has been extensive research on mucormycosis before the outbreak as a post-COVID complication, as indicated by the highest number of publications in 2019.Practical implicationsThe research hot spots have altered from “Mucormycosis,” “fungi,” “Zygomycosis” and “Drug efficacy”, “Drug Safety” to “Microbiology,” “Pathology,” “nucleotide sequence,” “surgical debridement” which indicates that potential area of research in the near future will be concerned with more extensive research in mucormycosis to develop standard treatment procedures to fight this infection. The quantity of scientific publications has also increased over time. The research and health community are called upon to join forces to activate existing knowledge, generate new insights and develop decision-supporting tools for health authorities in different nations to leverage vaccination in its transformational role toward successfully attaining nil cases of COVID-19.Originality/valueThe analysis of collaboration, findings, the research networks and visualization makes this study novel and separates from traditional metrics analysis. To the best of the authors’ knowledge, this work is original, and no similar studies have been found with the objectives included here.

show abstract

“…[23][24][25] Two other bibliometric studies that focussed on CAM and included publications till May and August 2021, respectively, provided analyses of 154 and 51 publications only, far lower than would be expected of an intensely researched topic. 26,27 Thus a comprehensive mapping of CAM research is still lacking. In the present contribution, we attempted to provide a bibliometric assessment of published research on CAM using the Scopus database.…”

Section: General Description Of Cam Publicationsmentioning

confidence: 99%

Scientometric Mapping of Mucormycosis Research in Relation to the COVID-19 Pandemic

Dayal¹,

Gupta²,

Kappi³

2022

IJMEDPH

View full text Add to dashboard Cite

Background:Mucormycosis is an invasive fungal infection that has shown a surge during the COVID-19 pandemic. A comprehensive assessment of COVID-19 associated mucormycosis (CAM) research is lacking. Methods: We searched Elsevier's Scopus database for publications on CAM using a pre-defined search strategy. Data on publications numbers, citation metrics, contributing countries, institutions, authors, journals, and the most cited articles were analyzed using select bibliometric tools. Results: Published CAM research included 253 publications. These were cited 1560 times, averaging 6.1 citations per paper. Only 33 (13%) were funded. Original articles (55.7%) and reviews (17.7%) constituted the major share of global output. The studied age groups included adults (22.5%), middle-aged (19.3%), elderly (10.6%), and adolescents (0.8%). Studies on treatment accounted for the largest share (58.5%), followed by clinical studies (28.0%), complications (17.3%), risk factors (11.7%), epidemiology (7.9%), and pathophysiology (3.1%). The participating countries were 64; India, the USA, and Egypt led in productivity, whereas France, the USA, and Iran were more impactful. Of the 84 organizations, the leading organizations were PGIMER-Chandigarh, AIIMS-New Delhi and Cairo University, Egypt. A. Chakrabarti, V. Muthu, and S.M. Rudramurthy were the most productive of 160 participating authors. Indian Journal of Ophthalmology, Indian Journal of Otolaryngology and Head and Neck Surgery, and Journal of Fungi were the most active journals that published CAM research. Conclusion: Research on CAM has primarily been conducted in middleincome countries and is low on quality. High-income countries need to collaborate with lowand middle-income countries for a sustainable and universal CAM research impact. There is also a need to focus on research gaps such as pathophysiology and epidemiology in future CAM research.

show abstract

Publications on Post-Covid Mucormycosis: A Bibliometric Study of WHO Database.

Cited by 6 publications

References 8 publications

Evaluation of the effect of the COVID-19 pandemic on mucormycosis studies with bibliometric analysis

Evaluation of the effect of the COVID-19 pandemic on mucormycosis studies with bibliometric analysis

Cluster analysis and network visualization of research in mucormycosis: a scientometric mapping of the global publications from 2011 to 2020

Scientometric Mapping of Mucormycosis Research in Relation to the COVID-19 Pandemic

Contact Info

Product

Resources

About